Compliance & regulatory monitoring · 50 states + DC + federal
RxVanceCompounding compliance.
State by state.
Alhaji Jalloh
Dual MS · PMP · Johns Hopkins · WuXi AppTec
My background is in analytical and quality work in GMP, GLP, and CLIA-regulated labs, including SOPs, CAPA programs, cGMP records, and FDA inspection preparation. RxVance applies that experience to compliance monitoring for 503A and 503B compounding pharmacies.
My team and I track changing requirements across all 50 states, DC, and the FDA. Each state adopts and enforces rules differently. A missed change can put a license at risk. We track what each state requires and enforces beyond the USP baseline, from the primary source.
It's free. The monthly report and critical alerts cost nothing to receive. Register for the states where you operate or ship, and we send them to you.
Alhaji Jalloh
Coverage
What we monitor
Every month we monitor all 50 states, the District of Columbia, and the federal level for both adopted rules and pending legislation affecting 503A pharmacies and 503B outsourcing facilities.
Reports & alerts
Your states. Your monthly report.
Monthly reports and critical alerts for the states you operate in or ship into. Free to receive.
Monthly Compliance & Regulatory Report
Board of pharmacy meeting outcomes, regulatory decisions, new rules, enforcement actions, and proposed legislation across the states you follow. What happened, what it means, and the specific action your compliance team needs to take.
Critical Alerts, as they happen
Emergency rules, new laws, state and FDA enforcement actions, and approaching deadlines, delivered the same week they happen.
Every item is sourced from official state board and legislative websites, FDA records, and confirmed government documents, never secondary write-ups.
Register for the report
For 503A and 503B compounding pharmacies. No charge for reports or alerts.
Include the states you operate in and ship into.
We send the monthly report and alerts for your states. We don't sell or share your information, and you can unsubscribe from any email.
How the monitoring works
Primary sources only. Every item traces to a government primary source: a board's own rule, notice, agenda, or order, an FDA docket, the Federal Register, or a state bill. Where something can't be confirmed at the source, it's stated as unconfirmed rather than inferred.
Beyond the baseline. USP is where compounding standards start, not where they end. States adopt those standards on their own terms, each can modify them, add requirements, or enforce them differently, and layer on licensing, renewal, and inspection rules USP never covers. We track what each state actually requires, so a setup that's compliant in one state isn't assumed to be compliant everywhere.
Independent and free. RxVance doesn't endorse or refer suppliers, and there's no charge to receive the report or the alerts. It isn't legal advice.
RxVance Platform
See every state update in one place
Open the RxVance Platform to browse the full state-by-state record and alert history, then create your free account. Signup takes about a minute.